New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.

RECURSOS

/

ENCUENTRA UN ESPECIALISTA

/

CONTACTO

Brian Kennedy

Brian Kennedy is a four-time Grammy Award–winning songwriter and producer, as well as a passionate advocate for rare kidney disease patients. Diagnosed with focal segmental glomerulosclerosis (FSGS) at the height of his music career, he later received a life-saving kidney transplant, an experience that now fuels his commitment to awareness, early detection, and health equity. Kennedy is the founder of Hits to Healing, a nonprofit dedicated to addressing health disparities through music, education, and community engagement. Drawing on both his personal journey and professional success, he brings a powerful voice and deep dedication to advancing NephCure’s mission.

Los Ángeles, California

Noticias relacionadas

NOTICIAS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NOTICIAS

NephCure Specialist of the Month: Dr. Rupali Avasare

NOTICIAS

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

NOTICIAS

NephCure Specialist of the Month: Dr. Fahad Aziz

Regístrese para recibir las últimas actualizaciones de NephCure.

INSCRIBIRSE
Este campo es para fines de validación y no debe modificarse.